期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
IGF2BP3-induced activation of EIF5B contributes to progression of hepatocellular carcinoma cells
1
作者 XIAOYIN LI QIAN WANG +4 位作者 HONGFENG LIANG SHISHENG CHEN HAIWEN CHEN YAOYONG LU CHANGFU YANG 《Oncology Research》 SCIE 2022年第2期77-87,共11页
In this study,we investigated the functional role of eukaryotic initiation factor 5B(EIF5B)in hepatocellular carcinoma(HCC)and the underlying mechanisms.Bioinformatics analysis demonstrated that the EIF5B transcript a... In this study,we investigated the functional role of eukaryotic initiation factor 5B(EIF5B)in hepatocellular carcinoma(HCC)and the underlying mechanisms.Bioinformatics analysis demonstrated that the EIF5B transcript and protein levels as well as the EIF5Bcopy number were significantly higher in the HCC tissues compared with the non-cancerous liver tissues.Down-regulation of EIF5B significantly decreased proliferation and invasiveness of the HCC cells.Furthermore,EIF5B knockdown suppressed epithelial-mesenchymal transition(EMT)and the cancer stem cell(CSC)phenotype.Down-regulation of EIF5B also increased the sensitivity of HCC cells to 5-fluorouracil(5-FU).In the HCC cells,activation of the NF-kappa B signaling pathway and IkB phosphorylation was significantly reduced by EIF5B silencing.IGF2BP3 increased the stability of the EIF5B mRNA in an m6A-dependent manner.Our data suggested that EIF5B is a promising prognostic biomarker and therapeutic target in HCC. 展开更多
关键词 EIF5B nf-jb Epithelial-mesenchymal transition Cancer stem cells N6-methyladenosine Hepatocellular carcinoma
下载PDF
构建重定向的NF-κB/OIP5表达程序以增强化疗对膀胱癌的治疗效果
2
作者 郑彬彬 牛立慢 +5 位作者 徐海波 杨育宾 陈延萍 王晨光 陈巍 黄卫人 《Science Bulletin》 SCIE EI CAS CSCD 2023年第24期3207-3224,M0006,共19页
NF-κB是重要的转录调控因子,对下游肿瘤耐药基因起关键调控作用.基于CRISPR基因编辑技术,可在膀胱癌中构建人工合成的基因表达程序,以重编程肿瘤药物应答过程.本研究发现Opa相互作用蛋白5(OIP5)在NF-κB激活后上调,并引起膀胱癌对长春... NF-κB是重要的转录调控因子,对下游肿瘤耐药基因起关键调控作用.基于CRISPR基因编辑技术,可在膀胱癌中构建人工合成的基因表达程序,以重编程肿瘤药物应答过程.本研究发现Opa相互作用蛋白5(OIP5)在NF-κB激活后上调,并引起膀胱癌对长春新碱耐药.通过整合连接靶向OIP5的引导RNA与NF-κB的适配体RNA,成功获得兼具编码靶向位点和调控功能的模块化RNA.此模块化RNA可识别并与长春新碱活化的NF-κB相结合,促使NF-κB从上调逆转为下调OIP5表达,并阻断多条NF-κB介导的耐药通路,从而高效阻止肿瘤耐药的发生.本研究还开发了一种纳米递药系统共递送模块化RNA和长春新碱,体内外实验表明两者协同增强药物的抗肿瘤疗效.通过基于纳米递药系统的联合治疗策略,我们证实了CRISPR技术在膀胱癌中构建人工合成基因表达程序的有效性,可重编程肿瘤的药物应答过程,达到增强膀胱癌化疗敏感性的目的. 展开更多
关键词 Drug resistance Gene circuit RNA engineering nf-jb OIP5 VINCRISTINE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部